<p>Digital twins (DTs) can transform randomized clinical trials by improving ethical standards, including safety, informed consent, equity, and data privacy. They also enhance trial efficiency by enabling early detection of adverse events and streamlined design. This paper explores the role of DTs in personalized medicine, from pre-clinical research to post-marketing, while addressing technological, legal, and ethical challenges in implementation.</p>

错误:搜索内容不能为空,请输入英文关键词
错误:关键词超出字数限制,请精简
高级检索

Enhancing randomized clinical trials with digital twins

  • Hossein Akbarialiabad,
  • Amirmohammad Pasdar,
  • Dédée F. Murrell,
  • Mehrnaz Mostafavi,
  • Farhan Shakil,
  • Ehsan Safaee,
  • Sancy A. Leachman,
  • Alireza Haghighi,
  • Michelle Tarbox,
  • Christopher G. Bunick,
  • Ayman Grada

摘要

Digital twins (DTs) can transform randomized clinical trials by improving ethical standards, including safety, informed consent, equity, and data privacy. They also enhance trial efficiency by enabling early detection of adverse events and streamlined design. This paper explores the role of DTs in personalized medicine, from pre-clinical research to post-marketing, while addressing technological, legal, and ethical challenges in implementation.